DK3365684T3 - Fremgangsmåde til berigelse af cellefrie nukleosomer - Google Patents

Fremgangsmåde til berigelse af cellefrie nukleosomer Download PDF

Info

Publication number
DK3365684T3
DK3365684T3 DK16787545.9T DK16787545T DK3365684T3 DK 3365684 T3 DK3365684 T3 DK 3365684T3 DK 16787545 T DK16787545 T DK 16787545T DK 3365684 T3 DK3365684 T3 DK 3365684T3
Authority
DK
Denmark
Prior art keywords
enrichment
procedure
cell
free nucleosomes
nucleosomes
Prior art date
Application number
DK16787545.9T
Other languages
English (en)
Inventor
Jacob Vincent Micallef
Mark Edward Eccleston
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Application granted granted Critical
Publication of DK3365684T3 publication Critical patent/DK3365684T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/12Post-translational modifications [PTMs] in chemical analysis of biological material alkylation, e.g. methylation, (iso-)prenylation, farnesylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16787545.9T 2015-10-21 2016-10-21 Fremgangsmåde til berigelse af cellefrie nukleosomer DK3365684T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1518665.3A GB201518665D0 (en) 2015-10-21 2015-10-21 Method for enrichment of cell free nucleosomes
PCT/GB2016/053305 WO2017068371A1 (en) 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes

Publications (1)

Publication Number Publication Date
DK3365684T3 true DK3365684T3 (da) 2020-12-21

Family

ID=55131411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16787545.9T DK3365684T3 (da) 2015-10-21 2016-10-21 Fremgangsmåde til berigelse af cellefrie nukleosomer

Country Status (12)

Country Link
US (2) US10746746B2 (da)
EP (2) EP3798634A1 (da)
JP (1) JP6831841B2 (da)
CN (1) CN108603884A (da)
AU (1) AU2016341501B2 (da)
CA (1) CA3002505A1 (da)
DK (1) DK3365684T3 (da)
ES (1) ES2830800T3 (da)
GB (1) GB201518665D0 (da)
PL (1) PL3365684T3 (da)
SG (1) SG11201803161YA (da)
WO (1) WO2017068371A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2930180T3 (es) 2012-03-02 2022-12-07 Sequenom Inc Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
WO2014168711A1 (en) 2013-03-13 2014-10-16 Sequenom, Inc. Primers for dna methylation analysis
EP3736344A1 (en) 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA3084620C (en) * 2017-09-18 2024-06-18 Santersus Sa Method and device for purification of blood from circulating cell free dna
ES2960550T3 (es) * 2018-03-01 2024-03-05 Epicypher Inc Cuantificación de modificaciones de nucleosoma utilizando nucleosomas recombinantes definidos químicamente
EP3765638A2 (en) * 2018-03-13 2021-01-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Diagnostic use of cell free dna chromatin immunoprecipitation
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
EP3757227A1 (en) * 2019-06-25 2020-12-30 Aarhus Universitet Cell-free chromatin immunoprecipitation (cfchip) as a measure of tumour gene expression in a sample
CN114901832A (zh) 2019-08-27 2022-08-12 比利时意志有限责任公司 分离循环核小体的方法
GB201912251D0 (en) 2019-08-27 2019-10-09 Belgian Volition Sprl Method of isolating circulating nucleosomes
TW202242145A (zh) * 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
WO2024042210A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
GB202300607D0 (en) 2023-01-16 2023-03-01 Belgian Volition Srl Proteins and methods for isolating circulating nucleosomes
CN117904196B (zh) * 2024-01-05 2024-07-12 安徽大学 一种非小细胞肺癌组蛋白h1.4赖氨酸乙酰化点突变细胞模型的构建及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
HUE061110T2 (hu) 2009-11-05 2023-05-28 Univ Hong Kong Chinese Magzati genomelemzés anyai biológiai mintából
WO2011092715A2 (en) 2010-01-27 2011-08-04 Tata Memorial Centre Method for in-vivo binding of chromatin fragments
US8981066B2 (en) 2011-08-23 2015-03-17 Buck Institute For Research On Aging Epigenetic mechanisms related to DNA damage and aging
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
GB201115099D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
RU2634266C2 (ru) * 2011-12-07 2017-10-24 Белджиан Волишн Спрл Способ детекции аддуктов нуклеосом
ES2930180T3 (es) * 2012-03-02 2022-12-07 Sequenom Inc Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica

Also Published As

Publication number Publication date
WO2017068371A1 (en) 2017-04-27
PL3365684T3 (pl) 2021-05-04
EP3365684B1 (en) 2020-09-23
CN108603884A (zh) 2018-09-28
CA3002505A1 (en) 2017-04-27
AU2016341501B2 (en) 2022-09-08
US20190064184A1 (en) 2019-02-28
SG11201803161YA (en) 2018-05-30
AU2016341501A1 (en) 2018-05-10
EP3798634A1 (en) 2021-03-31
GB201518665D0 (en) 2015-12-02
JP6831841B2 (ja) 2021-02-17
US10746746B2 (en) 2020-08-18
EP3365684A1 (en) 2018-08-29
JP2019500582A (ja) 2019-01-10
US20200340997A1 (en) 2020-10-29
ES2830800T3 (es) 2021-06-04

Similar Documents

Publication Publication Date Title
DK3365684T3 (da) Fremgangsmåde til berigelse af cellefrie nukleosomer
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3201361T3 (da) Fremgangsmåder til kvantificering af cellefrit DNA
DK3048295T3 (da) Fremgangsmåde til opførelse af en vindmølle og vindmølle
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3166612T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxy-picolinsyre
DK3191498T3 (da) Fremgangsmåde til fremstilling af 2'-o-fucosyllactose
DK3390422T3 (da) Krystalformer af lnt
DK3487986T3 (da) Fremgangsmåde til mikrobiel fremstilling af specifikke naturlige capsaicinoider
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK3137449T3 (da) Fremgangsmåder til fremstilling af substituerede cycloseriner
DK3277801T3 (da) Fremgangsmåde til fremstilling af otiske progenitorer
DK3328574T3 (da) Fremgangsmåde til fremstilling af en monotektisk legering
DK3529236T3 (da) Krystalformer af eravacyclin
DK3116854T3 (da) Ny fremgangsmåde til fremstilling af prostaglandiner med høj renhed